Abstract
This Viewpoint explores the current barriers to implementing contingency management treatment for individuals experiencing both opioid use and stimulant use disorders in the context of high numbers of US overdoses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have